Migraine Care Costs Drop: Insights from Colombia's Data Study
- Mar 31
- 1 min read
Research Summary
A study published in Neurologia (English Edition) examines the real-world healthcare resource utilization for migraine in Colombia, using data from the Information System for Social Protection. Between 2017 and 2021, researchers identified 293,028 new and 1,711,794 existing migraine cases, noting higher rates among women. Trends showed increased use of prophylactic treatments and neurology visits. Although pharmaceutical costs were the largest economic factor, they declined during the study. The annual healthcare cost per patient dropped from PPP$110 in 2017 to PPP$39 in 2019. The findings emphasize the need for improved education and treatment strategies, informing public health policies for migraine management.
Study Details
👥 Research Team: Sobrino F et al.
📚 Published In: Neurologia (Engl Ed)
📅 Publication Date: 2026 Mar 28
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.